- ►annals.org [PDF] JN Galgiani, A Catanzaro, GA Cloud, RH … - Annals of internal medicine, 2000 - Am Coll Physicians John N. Galgiani, MD; Antonino Catanzaro, MD; Gretchen A. Cloud, MS; Royce H.
Johnson, MD; Paul L. Williams, MD; Laurence F. Mirels, MD; Faris Nassar, MD; Jon
E. Lutz, MD; David A. Stevens, MD; P. Kay Sharkey, MD; Vipul R. Singh, MD; ... Cited by 105 - Related articles - BL Direct - All 5 versions
A Catanzaro, JN Galgiani, BE Levine, PK … - The American journal of medicine, 1995 - Elsevier This was a multiCenter, open-label, single-arm study. Of 78 patients enrolled,
22 had soft-tissue, 42 had chronic pulmonary, and 14 had skeletal
coccidioidomycosis. Forty-nine had at least one concomitant disease, 7 of ... Cited by 74 - Related articles - BL Direct - All 5 versions
- ►nih.gov [PDF] JN Galgiani, NM Ampel, JE Blair, A … - Clinical infectious diseases, 2005 - UChicago Press Featured in New York Times "Searching the Web for Flu Outbreaks" November 28,
2008 Using Internet Searches for Influenza Surveillance Philip M. Polgreen,
Yiling Chen, David M. Pennock, and Forrest D. Nelson One study, published ... Cited by 389 - Related articles - BL Direct - All 23 versions
JR Graybill, DA Stevens, JN Galgiani, WE … - The American Journal of Medicine, 1990 - Elsevier : Patients with osteoarticular, chronic pulmonary, and soft tissue disease
improved at similar rates. Because two patients had no scoring assessment for
efficacy, they were considered inassessable for efficacy. Forty-seven ... Cited by 78 - Related articles - All 2 versions
RM Tucker, DW Denning, EG Arathoon, MG … - Journal of the American Academy of Dermatology, 1990 - Elsevier Itraconazole, a new oral triazole antifungal agent, was administered in 75
courses to patients with chronic coccidioidomycosis at dosages of 50 to 400
mg/day for a median duration of 10 months. Assessment of efficacy was made ... Cited by 54 - Related articles - All 4 versions
- ►annals.org DH Dewsnup, JN Galgiani, JR Graybill, M … - Annals of internal medicine, 1996 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Is It Ever Safe To Stop Azole Therapy for Coccidioides immitis Meningitis? Cited by 80 - Related articles - BL Direct - All 3 versions
KJ Cortez, TJ Walsh, JE Bennett - Clinical Infectious Diseases, 2003 - UChicago Press Featured in New York Times "Searching the Web for Flu Outbreaks" November 28,
2008 Using Internet Searches for Influenza Surveillance Philip M. Polgreen,
Yiling Chen, David M. Pennock, and Forrest D. Nelson One study, published ... Cited by 56 - Related articles - BL Direct - All 5 versions
- ►annals.org JN Galgiani, A Catanzaro, GA Cloud, J Higgs, … - Annals of internal medicine, 1993 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Objective: To determine the efficacy and safety of fluconazole treatment of ... Cited by 120 - Related articles - All 4 versions
CW Woods, C McRill, BD Plikaytis, NE … - The Journal of infectious diseases, 2000 - UChicago Press Featured in US News & World Report "Common Cold Virus Alters Body's Genes"
October 24, 2008 Comparison of the Safety and Immunogenicity of 2 Respiratory
Syncytial Virus (RSV) Vaccines— Nonadjuvanted Vaccine or Vaccine ... Cited by 49 - Related articles - BL Direct - All 6 versions
JN Galgiani, DA Stevens, JR Graybill, WE … - The American journal of medicine, 1988 - ncbi.nlm.nih.gov One hundred and twelve patients with progressive pulmonary, skeletal, or soft
tissue infections caused by Coccidioides immitis were randomly assigned to
treatment with 400 or 800 mg per day dosages of ketoconazole. During ... Cited by 52 - Related articles - All 2 versions
